Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

2018 Belgian guidelines for the screening for latent tuberculosis in HIV-infected patients.

Wyndham-Thomas C, Dirix V, Goffard JC, Henrard S, Wanlin M, Callens S, Mascart F, Van Vooren JP.

Acta Clin Belg. 2019 Aug;74(4):242-251. doi: 10.1080/17843286.2018.1494669. Epub 2018 Jul 23.

PMID:
30036162
2.

Screening for Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Men Who Have Sex With Men: Diagnostic Accuracy of Nucleic Acid Amplification Test on Pooled Urine, Anorectal, and Pharyngeal Specimens.

Thielemans E, Wyndham-Thomas C, Henrard S, De Vleeschouwer A, Steensels D, Montesinos I, Debaisieux L, Delforge ML, Van Vooren JP, Goffard JC.

Sex Transm Dis. 2018 Mar;45(3):195-198. doi: 10.1097/OLQ.0000000000000722.

PMID:
29419710
3.

Make Refugee Health Care Great [Again].

Philbrick AM, Wicks CM, Harris IM, Shaft GM, Van Vooren JS.

Am J Public Health. 2017 May;107(5):656-658. doi: 10.2105/AJPH.2017.303740. No abstract available.

4.

Isolation unit for multidrug-resistant tuberculosis patients in a low endemic country, a step towards the World Health Organization End TB Strategy.

Payen MC, VAN Vooren JP, Vandenberg O, Clumeck N, DE Wit S.

Epidemiol Infect. 2017 May;145(7):1368-1373. doi: 10.1017/S0950268817000267. Epub 2017 Feb 16.

PMID:
28202091
5.

Immune Activation by Mycobacterium tuberculosis in HIV-Infected and -Uninfected Subjects.

Wyndham-Thomas C, Corbière V, Selis E, Payen MC, Goffard JC, Van Vooren JP, Mascart F, Dirix V.

J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):103-111.

PMID:
27532475
6.

[HIV infection : Reaching a zero risk of transmission].

Henrard S, Wyndham-Thomas C, Van Vooren JP, Goffard JC.

Rev Med Brux. 2016;37(4):315-321. French.

PMID:
28525231
7.

Implementation of latent tuberculosis screening in HIV care centres: evaluation in a low tuberculosis incidence setting.

Wyndham-Thomas C, Schepers K, Dirix V, Mascart F, Van Vooren JP, Goffard JC.

Epidemiol Infect. 2016 Mar;144(4):703-11. doi: 10.1017/S0950268815001594. Epub 2015 Jul 27.

PMID:
26211466
8.

The vascularised fibular graft for limb salvage after bone tumour surgery: a multicentre study.

Hilven PH, Bayliss L, Cosker T, Dijkstra PD, Jutte PC, Lahoda LU, Schaap GR, Bramer JA, van Drunen GK, Strackee SD, van Vooren J, Gibbons M, Giele H, van de Sande MA.

Bone Joint J. 2015 Jun;97-B(6):853-61. doi: 10.1302/0301-620X.97B6.34692.

PMID:
26033069
9.

Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.

Wyndham-Thomas C, Dirix V, Schepers K, Martin C, Hildebrand M, Goffard JC, Domont F, Libin M, Loyens M, Locht C, Van Vooren JP, Mascart F.

BMC Infect Dis. 2015 Feb 14;15:59. doi: 10.1186/s12879-015-0796-0.

10.

[Screening for tuberculosis].

Van Vooren JP, Schepers K.

Rev Med Brux. 2013 Sep;34(4):301-5. Review. French.

PMID:
24195244
11.

Long-incubation-time gamma interferon release assays in response to purified protein derivative, ESAT-6, and/or CFP-10 for the diagnosis of Mycobacterium tuberculosis infection in children.

Schepers K, Mouchet F, Dirix V, De Schutter I, Jotzo K, Verscheure V, Geurts P, Singh M, Van Vooren JP, Mascart F.

Clin Vaccine Immunol. 2014 Feb;21(2):111-8. doi: 10.1128/CVI.00525-13. Epub 2013 Oct 23.

12.

IL-12Rβ1 deficiency and disseminated Mycobacterium tilburgii disease.

Schepers K, Schandené L, Bustamante J, Van Vooren JP, de Suremain M, Casanova JL, Yombi JC, Jacobs F, Mascart F, Goffard JC.

J Clin Immunol. 2013 Nov;33(8):1285-8. doi: 10.1007/s10875-013-9941-y. Epub 2013 Oct 10.

PMID:
24114017
13.

Outcome after pollicization: comparison of patients with mild and severe longitudinal radial deficiency.

de Kraker M, Selles RW, van Vooren J, Stam HJ, Hovius SE.

Plast Reconstr Surg. 2013 Apr;131(4):544e-51e. doi: 10.1097/PRS.0b013e3182818c98.

PMID:
23542272
14.

Changes of mandibular ramal height, during growth in unilateral hemifacial microsomia patients and unaffected controls.

Ongkosuwito EM, van Vooren J, van Neck JW, Wattel E, Wolvius EB, van Adrichem LN, Kuijpers-Jagtman AM.

J Craniomaxillofac Surg. 2013 Mar;41(2):92-7. doi: 10.1016/j.jcms.2012.05.006. Epub 2012 Jul 11.

PMID:
22789870
15.

Hemodiafiltration with online regeneration of ultrafiltrate for severe nevirapine intoxication in a HIV-infected patient.

Hougardy JM, Husson C, Mackie NE, Van Vooren JP, Gastaldello K, Nortier JL, Goffard JC.

AIDS. 2012 Mar 13;26(5):653-5. doi: 10.1097/QAD.0b013e3283509770. No abstract available.

PMID:
22398572
16.

[Which immunizations for which adults in 2011?].

Goffard JC, Schepers K, Van Vooren JP.

Rev Med Brux. 2011 Sep;32(4):321-7. French.

PMID:
22034763
17.

[Pulmonary tuberculosis].

Van Vooren JP, Schepers K, Wanlin M.

Rev Med Brux. 2010 Sep;31(4):260-6. French.

PMID:
21089402
18.

T cell reactivity against mycolyl transferase antigen 85 of M. tuberculosis in HIV-TB coinfected subjects and in AIDS patients suffering from tuberculosis and nontuberculous mycobacterial infections.

Launois P, Drowart A, Bourreau E, Couppie P, Farber CM, Van Vooren JP, Huygen K.

Clin Dev Immunol. 2011;2011. pii: 640309. doi: 10.1155/2011/640309. Epub 2010 Sep 27.

19.

Outcomes of medication therapy review in a family medicine clinic.

Harris IM, Westberg SM, Frakes MJ, Van Vooren JS.

J Am Pharm Assoc (2003). 2009 Sep-Oct;49(5):623-7. doi: 10.1331/JAPhA.2009.08069.

PMID:
19748869
20.

Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis.

Hougardy JM, Schepers K, Place S, Drowart A, Lechevin V, Verscheure V, Debrie AS, Doherty TM, Van Vooren JP, Locht C, Mascart F.

PLoS One. 2007 Oct 3;2(10):e926.

21.

Paradoxical worsening of tuberculosis in a heart-lung transplant recipient.

Place S, Knoop C, Remmelink M, Baldassarre S, Van Vooren JP, Jacobs F, Mascart F, Estenne M.

Transpl Infect Dis. 2007 Sep;9(3):219-24.

PMID:
17692068
22.

Ethical issues in endoscopy: patient satisfaction, safety in elderly patients, palliation, and relations with industry. Second European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, July 2006.

Ladas SD, Novis B, Triantafyllou K, Schoefl R, Rokkas T, Stanciu C, Isaacs P, Willich SN, Ronn O, Dremel H, Livadas G, Egan BJ, Boyacioglu S, Selimovic A, Pulanic R, Karagiannis JA, Van Vooren JP, Kouroumalis E, O'Morain C, Nowak A, Deviere J, Malfertheiner P, Axon A.

Endoscopy. 2007 Jun;39(6):556-65. No abstract available.

23.

Hepatitis C virus is not a cofactor for Kaposi's sarcoma development in HIV-infected patients.

Schepers K, Van Vooren JP, Simonart T.

Int J Dermatol. 2006 Aug;45(8):994-5. No abstract available.

PMID:
16911398
24.

Medically assisted reproduction in the presence of chronic viral diseases.

Englert Y, Lesage B, Van Vooren JP, Liesnard C, Place I, Vannin AS, Emiliani S, Delbaere A.

Hum Reprod Update. 2004 Mar-Apr;10(2):149-62. Review.

PMID:
15073144
25.

[NTBR (Not to Be Resuscitated) in 10 questions].

Vincent JL, Van Vooren JP.

Rev Med Brux. 2002 Dec;23(6):497-9. French.

PMID:
12584945
26.

[The immunodeficiency treatment unit].

Van Vooren JP, Farber CM.

Rev Med Brux. 2002;23 Suppl 2:85-6. French.

PMID:
12584919
27.

Human herpesvirus 8 investigations: a role in the clinical management of Kaposi's sarcoma?

Simonart T, Hermans P, Van Vooren JP.

Dermatology. 2002;205(4):340-3.

PMID:
12444327
28.

Interleukin-1 beta increases the BCL-2/BAX ratio in Kaposi's sarcoma cells.

Simonart T, Van Vooren JP.

Cytokine. 2002 Sep 21;19(6):259-66.

PMID:
12421568
29.

[Medically assisted reproduction in couples carrying the human immunodeficiency virus].

Englert Y, Lesage B, Place I, Kirkpatrick C, Farber MC, Devrecker F, Liesnard C, Van Vooren JP.

Bull Mem Acad R Med Belg. 2002;157(1-2):103-9; discussion 109-10. French.

PMID:
12371274
30.
31.

Expression of the fibroblast/macrophage marker 1B10 by spindle cells in Kaposi's sarcoma lesions and by Kaposi's sarcoma-derived tumor cells.

Simonart T, Degraef C, Heenen M, Hermans P, Van Vooren JP, Noel JC.

J Cutan Pathol. 2002 Feb;29(2):72-8.

PMID:
12150136
32.

Desferrioxamine enhances AIDS-associated Kaposi's sarcoma tumor development in a xenograft model.

Simonart T, Boelaert JR, Andrei G, van den Oord JJ, Degraef C, Hermans P, Noel JC, Van Vooren JP, Heenen M, De Clercq E, Snoeck R.

Int J Cancer. 2002 Jul 10;100(2):140-3.

33.

Treatment of Kaposi's sarcoma with human chorionic gonadotropin.

Simonart T, Van Vooren JP, Meuris S.

Dermatology. 2002;204(4):330-3. Review.

PMID:
12077540
34.

Enhancement of classic Kaposi's sarcoma growth after intralesional injections of desferrioxamine.

Simonart T, Boelaert JR, Van Vooren JP.

Dermatology. 2002;204(4):290-2.

PMID:
12077524
35.

Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis.

Masungi C, Temmerman S, Van Vooren JP, Drowart A, Pethe K, Menozzi FD, Locht C, Mascart F.

J Infect Dis. 2002 Feb 15;185(4):513-20. Epub 2002 Jan 31.

PMID:
11865404
36.

High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier.

Kentos A, Vekemans M, Van Vooren JP, Lambermont M, Liesnard C, Feremans W, Farber CM.

Bone Marrow Transplant. 2002 Feb;29(3):273-5.

37.

Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals.

Dieye TN, Sow PS, Simonart T, Guèye-Ndiaye A, Popper SJ, Delforge ML, Dieye A, Sarr AD, Crusiaux A, Van Vooren JP, Devleeschouwer M, Kanki P, Mboup S, Diakhate L, Farber CM.

Vaccine. 2001 Dec 12;20(5-6):905-13.

PMID:
11738756
38.

Cultured Kaposi's sarcoma tumor cells exhibit a chemokine receptor repertoire that does not allow infection by HIV-1.

Simonart T, Debussher C, Liesnard C, Debaisieux L, Delforge ML, de Lavareille A, Hermans P, Van Vooren JP, Stordeur P.

BMC Dermatol. 2001;1:2. Epub 2001 Jul 24.

39.

Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer.

Tanghe A, Content J, Van Vooren JP, Portaels F, Huygen K.

Infect Immun. 2001 Sep;69(9):5403-11.

40.

[Iron and Kaposi's sarcoma].

Simonart T, Boelaert JR, Van Vooren JP, Heenen M.

Ann Dermatol Venereol. 2001 May;128(5):659-61. Review. French. No abstract available.

PMID:
11427805
41.

ART in HIV-infected couples: has the time come for a change of attitude?

Englert Y, Van Vooren JP, Place I, Liesnard C, Laruelle C, Delbaere A.

Hum Reprod. 2001 Jul;16(7):1309-15. Review.

PMID:
11425804
42.

[Medically assisted reproduction and the desire for a child by HIV infected couples: has the time for a change in attitude come?]].

Englert Y, Van Vooren JP, Liesnard C, Laruelle C, Delbaere A.

Gynecol Obstet Fertil. 2001 May;29(5):339-48. Review. French.

PMID:
11406929
43.

[Immune deficiencies: diagnosis, management, some perspectives].

Farber CM, Benoit Y, Boven K, De Baets F, Ferster A, Hoyoux C, Mascart F, Otten J, Philippet P, Van Lierde S, Van Vooren JP, Vermylen C.

Rev Med Brux. 2001 Apr;22(2):73-82. Review. French.

PMID:
11388026
44.

Early- and late-stage Kaposi's sarcoma-derived cells but not activated endothelial cells can invade de-epidermized dermis.

Simonart T, Degraef C, Mosselmans R, Hermans P, Lunardi-Iskandar Y, Noel JC, Van Vooren JP, Parent D, Heenen M, Galand P.

J Invest Dermatol. 2001 May;116(5):679-85.

45.

Iron induces Bcl-2 expression in human dermal microvascular endothelial cells.

Simonart T, Degraef C, Stordeur P, Noel JC, Mosselmans R, Van Vooren JP, Parent D, Boelaert JR, Heenen M, Galand P.

Free Radic Res. 2001 Mar;34(3):221-35.

PMID:
11264898
46.

Value of standard laboratory tests for the early recognition of group A beta-hemolytic streptococcal necrotizing fasciitis.

Simonart T, Simonart JM, Derdelinckx I, De Dobbeleer G, Verleysen A, Verraes S, de Maubeuge J, Van Vooren JP, Naeyaert JM, de la Brassine M, Peetermans WE, Heenen M.

Clin Infect Dis. 2001 Jan;32(1):E9-12. doi: 10.1086/317525.

PMID:
11202110
47.

Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors.

Simonart T, Degraef C, Andrei G, Mosselmans R, Hermans P, Van Vooren JP, Noel JC, Boelaert JR, Snoeck R, Heenen M.

J Invest Dermatol. 2000 Nov;115(5):893-900.

48.

Kaposi's sarcoma.

Simonart T, Van Vooren JP, Meuris S.

N Engl J Med. 2000 Aug 24;343(8):582; author reply 583-4. No abstract available.

PMID:
10979789
50.

What are the immunologically active components of bacille Calmette-Guérin in therapy of superficial bladder cancer?

Zlotta AR, Van Vooren JP, Denis O, Drowart A, Daffé M, Lefèvre P, Schandene L, De Cock M, De Bruyn J, Vandenbussche P, Jurion F, Palfliet K, Simon J, Schulman CC, Content J, Huygen K.

Int J Cancer. 2000 Sep 15;87(6):844-52.

Supplemental Content

Loading ...
Support Center